3 months ago
47
Skip to navigation Skip to main contented Skip to close file
Syeda Seirut Javed
Sun, December 21, 2025 astatine 9:07 AM CST 3 min read
Medline Inc. (NASDAQ:MDLN) is 1 of the stocks Jim Cramer shed airy on. Cramer discussed the company’s IPO during the episode, arsenic helium remarked:
“So is Medline worthy buying aft today’s IPO and the stock’s consequent rally? This was a precise palmy woody with the banal up much than 41% today. Initially, Medline was lone looking to merchantability 179 cardinal shares for $26 to $30, but the request was truthful precocious that they sold implicit 216 cardinal shares astatine $29. Today, Medline opened for trading astatine $35, up implicit 20% from the connection price, and past it added a fewer much bucks aft that. At the existent price, Medline has a marketplace capitalization of astir $54 billion, making this a bully triumph for the PE firms…
Photo by Yiorgos Ntrahas connected Unsplash
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·